Ingrid is an intellectual property lawyer who handles patent prosecution and related matters for a broad range of biotechnology clients. She works extensively with universities, including inventors and engineers in academia and helps them patent their innovations and discoveries. Her practice spans the fields of immunology, microbiology, molecular biology, cardiovascular medicine, oncology, ophthalmology, clinical diagnostics, and medical devices. Ingrid also counsels clients on strategic issues, including patent portfolio management and licensing options. She draws on her previous experience as a technology transfer associate at a Boston-area cancer treatment institute.

Ingrid’s practice emphasizes patent prosecution in the area of biotechnology, particularly in the fields of molecular biology, immunology, microbiology, cardiovascular medicine, clinical diagnostics, and medical devices, and includes advising clients on issues relating to patent portfolio management and licensing. She has been a frequent speaker at Biotechnology Industry Organization and Association of University Technology Managers conferences.

Prior to joining Mintz, Ingrid was a technology transfer associate at the Dana-Farber Cancer Institute, and then practiced at another prominent Boston law firm.